Merck & Co. Inc.beginsa restructuring expected to eliminate 8,500 positions and generate savings of $2.5 billion by 2015 with no immediate plans to divest its consumer health business, which recently launched a first-in-class OTC switch, Oxytrol for Women overactive bladder patch.
CEO Kenneth Frazier on Oct
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?